KCK
Latest statistics and disclosures from KCK's latest quarterly 13F-HR filing:
- Top 5 stock holdings are NPCE, SGHT, ALRN, and represent 100.00% of KCK's stock portfolio.
- Reduced shares in these 1 stock: SGHT.
- KCK was a net seller of stock by $-15k.
- KCK has $70M in assets under management (AUM), dropping by 10.34%.
- Central Index Key (CIK): 0001657662
Tip: Access up to 7 years of quarterly data
Positions held by KCK consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Portfolio Holdings for KCK
KCK holds 3 positions in its portfolio as reported in the September 2023 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price | |
|---|---|---|---|---|---|---|
| Neuropace (NPCE) | 77.7 | $55M | 5.6M | 9.73 |
|
|
| Sight Sciences (SGHT) | 22.2 | $16M | 4.6M | 3.37 |
|
|
| Aileron Therapeutics Com New (ALRN) | 0.0 | $34k | 22k | 1.52 |
|
Past Filings by KCK
SEC 13F filings are viewable for KCK going back to 2021
- KCK 2023 Q3 filed Nov. 1, 2023
- KCK 2023 Q2 filed July 25, 2023
- KCK 2023 Q1 filed May 5, 2023
- KCK 2022 Q4 filed Jan. 31, 2023
- KCK 2022 Q3 filed Oct. 31, 2022
- KCK 2022 Q2 filed Aug. 10, 2022
- KCK 2022 Q1 filed May 11, 2022
- KCK 2021 Q4 filed Feb. 11, 2022